Clinical Trial Update: Regadenoson and Adenosine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Regadenoson and Adenosine for coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Adenosine (Adenosine)
• Lexiscan (regadenoson)

Snippet

Sponsor: Lokien van Nunen | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED